Princeton Alpha Management’s AbbVie ABBV Stock Holding History

Princeton Alpha Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-44,821	Closed	-$2.56M	–	750
2016 Q1	$2.56M	Buy	+44,821	New	+$2.5M	0.42%	48
2015 Q3	–	Sell	-79,761	Closed	-$5.36M	–	692
2015 Q2	$5.36M	Buy	79,761 +36,004	+82%	+$2.35M	1.06%	2
2015 Q1	$2.56M	Buy	+43,757	New	+$2.64M	0.55%	27
2014 Q2	–	Sell	-31,190	Closed	-$1.6M	–	659
2014 Q1	$1.6M	Buy	31,190 +23,017	+282%	+$1.16M	0.5%	30
2013 Q4	$432K	Buy	+8,173	New	+$402K	0.32%	86

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Princeton Alpha Management's ABBV Position: Q2 2016 in Review

Princeton Alpha Management sold out of AbbVie (ABBV) in Q2 2016, closing a stake of 44,821 shares — an estimated $2.56M sold.

Princeton Alpha Management first reported a position in ABBV in Q4 2013 and held it in 5 quarters. The position peaked at $5.36M in Q2 2015. 1,636 funds tracked by Wall St. Rank hold ABBV as of Q2 2016.

Princeton Alpha Management reported no remaining AbbVie position as of Q2 2016 after selling out during the quarter.
Princeton Alpha Management sold 44,821 AbbVie shares in Q2 2016, an estimated $2.56M.
Princeton Alpha Management first reported a position in AbbVie in Q4 2013 and held it in 5 quarters.
Princeton Alpha Management's AbbVie position peaked at $5.36M in Q2 2015.
1,636 funds tracked by Wall St. Rank held AbbVie as of Q2 2016.

Based on Princeton Alpha Management's 13F filing for Q2 2016, filed 5 Aug 2016.